Estimating the Risk of Cancer Associated With Imaging Related Radiation During Surveillance for Stage I Testicular Cancer Using Computerized Tomography

Journal of Urology

Volumn 181, Issue 2, 2009, Pages 627-633

  Tarin, Tatum V ^a   Sonn, Geoffrey ^a   Shinghal, Rajesh ^a  

^a SANTA CLARA VALLEY MEDICAL CENTER   (United States)

Author keywords

neoplasms; radiation induced; testicular neoplasms

Indexed keywords

ABDOMEN; ADULT; ARTICLE; ATTRIBUTABLE RISK; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CASE REPORT; COLON CANCER; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IONIZING RADIATION; LUNG CANCER; LYMPH NODE DISSECTION; MALE; MONTE CARLO METHOD; NON SEMINOMATOUS GERMINOMA; PELVIS; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION DOSE; SIMULATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; BIOPSY, NEEDLE; COHORT STUDIES; DIAGNOSTIC IMAGING; DOSE-RESPONSE RELATIONSHIP, RADIATION; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MONTE CARLO METHOD; NEOPLASM STAGING; NEOPLASMS, RADIATION-INDUCED; PREDICTIVE VALUE OF TESTS; RADIATION DOSAGE; REGISTRIES; RISK ASSESSMENT; SURVIVAL RATE; TESTICULAR NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 58149199525     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.10.005     Document Type: Article

References (20)

1. Swerdlow A.J., dos Santos Silva I., Reid A., Qiao Z., Brewster D.H., and Arrundale J. Trends in cancer incidence and mortality in Scotland: description and possible explanations. Br J Cancer 77 (1998) 1
2. Choueiri T.K., Stephenson A.J., Gilligan T., and Klein E.A. Management of clinical stage I nonseminomatous germ cell testicular cancer. Urol Clin North Am 34 (2007) 137
3. Read G., Stenning S.P., Cullen M.H., Parkinson M.C., Horwich A., Kaye S.B., et al. Medical Research Council prospective study of surveillance for stage I testicular teratoma. J Clin Oncol 10 (1992) 1762
4. Daugaard G., Peterson P.M., and Rorth M. Surveillance in stage I testicular cancer. APMIS 111 (2003) 76
5. NCCN Clinical Practice Guidelines in Oncology™: Testicular Cancer v.2.2008: National Comprehensive Cancer Network 2008.
6. Brenner D.J., and Hall E.J. Computed tomography-an increasing source of radiation exposure. N Engl J Med 357 (2007) 2277
7. National Research Council. Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2 (2005), The National Academies Press, Washington, D. C
8. Einstein A.J., Henzlova M.J., and Rajagopalan S. Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. JAMA 298 (2007) 317
9. Jones D.G., and Shrimpton P.C. Survey of CT Practice in the UK. Part 3: Normalised Organ Doses Calculated Using Monte Carlo Techniques. NRPB-R250 (1991), HMSO, London
10. Lewis M.A., Edyvean S., Sassi S.A., Kiremidjian H., Keat N., and Britten A.J. Estimating Patient Dose on Current CT Scanners: Results of the ImPACT* CT Dose Survey (2000), ImPACT, London
11. Jacobsen N.E., Foster R.S., and Donohue J.P. Retroperitoneal lymph node dissection in testicular cancer. Surg Oncol Clin N Am 16 (2007) 199
12. Rustin G.J., Mead G.M., Stenning S.P., Vasey P.A., Aass N., Huddart R.A., et al. Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197-the National Cancer Research Institute Testis Cancer Clinical Studies Group. J Clin Oncol 25 (2007) 1310
13. Harvey M.L., Geldart T.R., Duell R., Mead G.M., and Tung K. Routine computerised tomographic scans of the thorax in surveillance of stage I testicular non-seminomatous germ-cell cancer-a necessary risk?. Ann Oncol 13 (2002) 237
14. van den Belt-Dusebout A.W., de Wit R., Gietema J., Horenblas S., Louwman M.W., Ribot J.G., et al. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 25 (2007) 4370
15. Bajorin D.F. The graying of testis cancer patients: what have we learned?. J Clin Oncol 25 (2007) 4341
16. Sheinfeld J., Bartsch G., and Bosl G. Surgery for testicular tumors. In: Wein A.J., Kavoussi L.R., Novick A.C., Partin A.W., and Peters C.A. (Eds). Campbell-Walsh Urology. 9th ed. vol 1 (2007), WB Saunders, Philadelphia chapt 30
17. Baniel J., and Sella A. Complications of retroperitoneal lymph node dissection in testicular cancer: primary and post-chemotherapy. Semin Surg Oncol 17 (1999) 263
18. Chamie K., Kurzrock E.A., Romero V., and deVere White R.W. Increased risk of secondary malignancy in patients on active surveillance for NSGCT. J Urol 179 suppl. (2008) 172 abstract 492
19. Cardis E., Vrijheid M., Blettner M., Gilbert E., Hakama M., Hill C., et al. Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries. BMJ 331 (2005) 77
20. Hao D., Seidel J., Brant R., Alexander F., Ernst D.S., Summers N., et al. Compliance of clinical stage I nonseminomatous germ cell tumor patients with surveillance. J Urol 160 (1998) 768